Read more about Dr Mignonne C
Semaglutide and Tirzepatide are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Patients on GLP-1 programs such as semaglutide or tirzepatide sometimes use it as a complementary metabolic support injection
We've seen compelling data, extending into early 2026, demonstrating substantial reductions in body weight in various research models, often surpassing what's observed with other pharmacological interventions aimed at appetite control
BEFORE YOU BEGIN TAKING ANY NEW MEDICINE, either prescription or over-the-counter, check with your doctor or pharmacist
AOD-9604 does not affect the hypothalamic-pituitary axis, so there is no negative feedback loop to blunt the response over time